eFusion MMOG GmbH is proud to announce the successful finish of the close beta 2nd phase and is announcing now the final 3rd phase of our tests!
On the 24th of March, eFusion MMOG GmbH started the 2nd closed beta phase after finishing the changes which have been reported and collected within the 1st test earlier that month. In the 2nd phase the network tests have had the highest priority and based on the results we collected during this time, some adjustments will be made now. Additionally to the testers of the 1st phase, which supported us again ebulliently, we attracted another 3000 players to become a tester!
In the final CBT phase, we will now test the service before readying our systems for the planned Open Beta Test. Some major changes are expected which increase the quality of service for our players!
The 3rd closed beta phase will start on the 7th of April 2010.
As usual the reporting event for our testers will continue and offer a final additional chance to earn those special and unique items we are providing to the best reporters!
Finally this will be also the last chance for everyone to obtain a free beta key from our channel partners who will offer the left beta keys to their communities!
eFusion MMOG GmbH would like to say“Thank you” to all testers and partner sites who supported us until now, and is looking forward to another even more successful CBT phase.
eFusion MMOG GmbH is the official European publisher of Navy Field Europe and Blitz1941, and is based in Germany. Navy Field Europe has been started from August 2007 and it’s published to Pan-Europe.
Since 2009 eFusion has started the military gaming portal– www.twowar.com– and has added a new game
called Blitz1941 to offer something more for the ambitious military MMOG gamers.
eFusion MMOG GmbH is focusing on MMOGs and will publish more qualified Korean MMOGs to the European
eFusion MMOG GmbH
Phone: +49 (0)6196 - 998690 - 0
Fax: +49 (0)6196 - 998690 - 9
Mail to: firstname.lastname@example.org
CEO: Myoung Seon Lim
PR: Dennis Hilgersom
Mail to: email@example.com